Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

Recombinant Human IL13RA2/CD213A2 Protein (His & Fc Tag)(Active)– MSE Supplies LLC

Free Shipping on MSE PRO Online Orders of $500 or More! U.S. Orders Only * Offer Excludes Hazmat Shipments *

Menu

This product has been added to the cart.

Recombinant Human IL13RA2/CD213A2 Protein (His & Fc Tag)(Active)

SKU: PKSH031658-100

  • $ 72495
  • Save $ 8100



Recombinant Human IL13RA2/CD213A2 Protein (His & Fc Tag)(Active)

 

SKU # PKSH031658
Expression Host HEK293 Cells

 

 

Description

Synonyms IL13RA, CD213A, IL13RA2, CD213A2, CT19, IL-13R, IL13BP, IL13R, IL-13Ra2
Species Human
Expression Host HEK293 Cells
Sequence Met 1-Leu 342
Accession NP_000631.1
Calculated Molecular Weight 65.0 kDa
Observed Molecular Weight 90-100 kDa
Tag C-His-Fc
Bio-activity Immobilized recombinant human IL13RA2 at 8 μg/ml (100 μl/well) can bind IL13 with a linear range of 0.25-8.0 ng/ml.
  

 

Properties

Purity > 75 % as determined by reducing SDS-PAGE.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method.
Storage Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping This product is provided as lyophilized powder which is shipped with ice packs.
Formulation Lyophilized from sterile 100mM Glycine, 10mM NaCl, 50mM Tris, pH 7.5
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution Please refer to the printed manual for detailed information.



Background

Interleukin-13 receptor subunit alpha-2 (IL13RA2/IL-13RA2) is also known as also known as cluster of differentiation 213A2 (CD213A2), IL-13 receptor subunit alpha-2, IL-13R subunit alpha-2, and IL-13RA2. The IL13RA2 is often overexpressed in brain tumors, making Il13ra2 one of the vaccine targets for immunotherapy of glioma. IL13RA2/IL-13RA2 is a cancer-associated receptor that is present in greater than 80% of High Grade Astrocytomas (HGA) and has recently been recognized as a cytokine that predisposes breast cancer cells to metastasize. Expression of IL13R&alpha;2 was rapidly lost from the surface of transduced cells grown in culture. The loss appeared to be related to ligands present in fetal bovine serum in the medium. None of the malignant glioma cell lines cultivated in vitro and tested to date exhibited the IL13R&alpha;2 receptor. A recombinant virus (R5111) enters cells via its interaction with the IL13R&alpha;2 receptor in a manner that cannot be differentiated from the interaction of wild-type virus with its receptors.